At Rush University Medical Center, we are putting your safety first. For information about COVID-19, see the latest updates. Rush accepts donations to support our response effort, staff, and patients and families.
How you can devise a cancer prevention action plan.
How to love yourself — and your selfies — without filters or fillers.
Corticosteroid Lumbar Epidural Analgesia for Radiculopathy (C.L.E.A.R.) Study
Clinical Trial Title:
Corticosteroid Lumbar Epidural Analgesia for Radiculopathy (C.L.E.A.R.)
Clinical Trial Protocol ID:
17091601
Clinical Trial Investigator Name:
Matthew P. Jaycox, MD
Clinical Trial Protocol Description:
The purpose of this study includes the following:
- Compare the pain relief following a single epidural injection (into a fluid space that surrounds the spinal cord) of SP102 to placebo (a product that has no active drug).
- Evaluate SP102’s effect on your ability to do or not do certain things.
- Evaluate the safety of the epidural SP102 injection.
Clinical Trial Eligibility Criteria:
In order to participate you must meet the following criteria:
- Have low back pain radiating into your leg.
You will be excluded from the study if any of the following criteria apply to you:
- Have back pain that is greater than your leg pain.
This is a partial list of inclusion and exclusion criteria.
Clinical Trial Area:
Pain Management
Spine and Back Disorders
Contact Phone:
(312) 942-2741
Contact Name:
Nat Froikin